About this trial
CADS-D aimes to evaluate the effectiveness and feasibility of a newly DCBT program for Chinese adolescents with depressive symptoms.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 12 to 18 years;
Scored 28 or higher on the children's depression rating scale-revised (CDRS-R);
Have the ability to read and write in Chinese;
Participant and at least one of their guardians provided written consent;
Disqualifiers
The researchers assessed that the adolescent's depressive symptoms were too severe to participate to CADS-D;
Scored 5 or higher on item 13 (suicidal ideation) on CDRS-R;
Participants who met diagnosis of other mental disorder except depression;
Severe physical illnesses or other physical disabilities that prevented the use of DCBT;
Trial design
Parallel
Treatments tested in this trial
Digital cognitive behavioral therapy(DCBT)
Other interventionMoca is a mobile application designed to deliver structural CBT for adolescents with mood problems. Moca provides six-twelve guided sessions with an estimated proceeding duration of 25-45min each, developed to be processed weekly. The content of each session includes the introduction of the core concepts and principles of CBT, psychological counseling dialogue, skill exercises, and homework. Content presentation forms include text, animation, audio, comics, etc. At the end of each module, the participants will be asked to submit homework that will ask them to apply their learned skills to nursing or daily life situations that they personally perceive as stressful. Participants can review the completed sessions and record their mood status during the intervention period.
Regular mental health curriculum
Other interventionThe content of regular mental health curriculum includes mental health education lecture. Few lectures address the knowledge and skills involved in CBT in such education lecture.
Treatment groups
Trial outcomes
Primary outcomes
Change in CDRS-R (Children's Depression Rating Scale) scores from baseline
Children's Depression Rating Scale is a 17 items observer-rated scale developed specifically for children and adolescents. Total scores range from 17-113, with higher scores indicating greater severity of depressive symptoms.
Secondary outcomes
Feasibility of DCBT
Feasibility is assessmented by an acceptability and satisfaction questionnaire. The questionnaire constitutes 10 items which designed to examine acceptability and satisfaction with DCBT. In the first 8 questions, participants rated each item on a 5-point Likert scale. In last 2 questions, participants are asked to write the best and worst things about DCBT.
Changes in PHQ (9-item Patient Health Questionnaire) scores from baseline
Improvement in self-reported depressive symptoms. Total scores range from 0-27, with higher scores indicating greater severity of self-reported depressive symptoms.
Changes in GAD-7 (Generalized Anxiety Disorder 7-item Scale) scores from baseline
Improvement in self-reported anxiety symptom. Total scores range from 0-21, with higher scores indicating greater severity of self-reported anxiety symptoms.
Changes in CD-RISC ( Connor-Davidson Resilience Scale) scores from baseline
Improvement in psychological resilience assessed by Connor-Davidson Resilience Scale. Total scores range from 0-100, with higher total scores indicating stronger psychological resilience.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.